← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

AVR logoAnteris Technologies Global Corp.(AVR)Earnings, Financials & Key Ratios

AVR•NASDAQ
$6.51
$235M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryCardiovascular and heart rhythm devices
AboutAnteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.Show more
  • Revenue$3M-1.2%
  • EBITDA-$77M-63.6%
  • Net Income-$76M-65.8%
  • EPS (Diluted)-3.77-194.5%
  • Gross Margin46.84%+46.1%
  • EBITDA Margin-2843.69%-65.5%
  • Operating Margin-2899.45%-64.7%
  • Net Margin-2822.46%-67.7%
  • ROE-187.03%+43.2%
  • Debt/Equity0.02-73.6%
  • Interest Coverage-955.76-33.2%
Technical→

AVR Key Insights

Anteris Technologies Global Corp. (AVR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Share count reduced 43.6% through buybacks

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

AVR Price & Volume

Anteris Technologies Global Corp. (AVR) stock price & volume — 10-year historical chart

Loading chart...

AVR Growth Metrics

Anteris Technologies Global Corp. (AVR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-22.61%
TTM-21.09%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-18.59%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-81.73%

Return on Capital

10 Years-274.26%
5 Years-274.26%
3 Years-262.75%
Last Year-183.95%

AVR Recent Earnings

Anteris Technologies Global Corp. (AVR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 0/5 qtrs (0%)●Beat Revenue 2/5 qtrs (50%)
Q1 2026Latest
Feb 26, 2026
EPS
$0.75
Est $0.50
-49.0%
Revenue
$303,000
Est $200,000
+51.5%
Q4 2025
Nov 12, 2025
EPS
$0.62
Est $0.56
-10.7%
Revenue
$429,000
Est $307,500
+39.5%
Q3 2025
Aug 11, 2025
EPS
$0.58
Est $0.50
-16.0%
Revenue
$618,000
Est $1M
-49.7%
Q2 2025
May 13, 2025
EPS
$0.61
Est $0.45
-35.6%
Revenue
$556,000
Est $584,250
-4.8%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$0.75vs $0.50-49.0%
$303,000vs $200,000+51.5%
Q4 2025Nov 12, 2025
$0.62vs $0.56-10.7%
$429,000vs $307,500+39.5%
Q3 2025Aug 11, 2025
$0.58vs $0.50-16.0%
$618,000vs $1M-49.7%
Q2 2025May 13, 2025
$0.61vs $0.45-35.6%
$556,000vs $584,250-4.8%
Based on last 5 quarters of dataView full earnings history →

AVR Peer Comparison

Anteris Technologies Global Corp. (AVR) competitors in Cardiovascular and heart rhythm devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NVCR logoNVCRNovoCure LimitedDirect Competitor1.92B16.83-13.808.28%-25.66%-50.82%0.85
TMCI logoTMCITreace Medical Concepts, Inc.Direct Competitor122.34M1.92-2.061.59%-27.74%-67.56%0.16
ATRC logoATRCAtriCure, Inc.Direct Competitor1.41B27.80-115.8314.88%-0.83%-0.95%0.18
EW logoEWEdwards Lifesciences CorporationProduct Competitor47.72B82.7745.2311.55%17.64%10.35%0.07
XTNT logoXTNTXtant Medical Holdings, Inc.Product Competitor79.8M0.57-4.7528.44%1.32%3.77%0.82
AORT logoAORTArtivion, Inc.Product Competitor1.72B35.39168.5213.59%2.55%2.66%0.65
MDT logoMDTMedtronic plcSupply Chain99.94B77.9621.603.62%13%9.45%0.59
ABT logoABTAbbott LaboratoriesSupply Chain151.3B87.0111.394.59%31.88%27.26%0.32

Compare AVR vs Peers

Anteris Technologies Global Corp. (AVR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for AVR.

Scale Benchmark

vs ABT

Larger-name benchmark to compare AVR against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, TMCI, ATRC, EW

AVR Income Statement

Anteris Technologies Global Corp. (AVR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Sales/Revenue5.46M5.83M3.2M2.73M2.7M2.14M
Revenue Growth %-6.83%-45.1%-14.56%-1.16%-21.09%
Cost of Goods Sold2.1M3.93M2.9M1.86M1.44M685.76K
COGS % of Revenue38.47%67.32%90.68%67.94%53.16%-
Gross Profit
3.36M▲ 0%
1.91M▼ 43.3%
298.38K▼ 84.3%
876.8K▲ 193.9%
1.27M▲ 44.4%
1.45M▲ 0%
Gross Margin %61.53%32.68%9.32%32.06%46.84%67.94%
Gross Profit Growth %--43.27%-84.34%193.85%44.39%-
Operating Expenses16.62M18.77M31.41M49.02M79.64M87.44M
OpEx % of Revenue304.52%321.85%981.43%1792.32%2946.28%-
Selling, General & Admin2.63M9.14M15.21M17.05M00
SG&A % of Revenue48.27%156.68%475.31%623.28%--
Research & Development3.57M9.99M17.59M31.02M51.45M62.92M
R&D % of Revenue65.47%171.42%549.57%1134.32%1903.48%-
Other Operating Expenses10.41M-364.5K-1.39M949.48K28.19M4M
Operating Income
-13.26M▲ 0%
-16.86M▼ 27.1%
-31.11M▼ 84.5%
-48.14M▼ 54.7%
-78.37M▼ 62.8%
-85.99M▲ 0%
Operating Margin %-242.99%-289.18%-972.11%-1760.26%-2899.45%-4019.95%
Operating Income Growth %--27.14%-84.54%-54.72%-62.8%-
EBITDA-12.68M-16.22M-30.34M-46.98M-76.86M-84.35M
EBITDA Margin %-232.4%-278.2%-947.92%-1717.93%-2843.69%-3943.18%
EBITDA Growth %--27.88%-87.05%-54.85%-63.6%-15.48%
D&A (Non-Cash Add-back)577.52K640.09K774.08K1.16M1.51M1.64M
EBIT-14.63M-16.14M-29.92M-46.7M-78.37M-86.38M
Net Interest Income-300.64K-965.64K-438.33K360.97K-82K-105.85K
Interest Income068.55K210.38K428.06K00
Interest Expense300.64K1.03M648.71K67.09K82K105.85K
Other Income/Expense1.48M-310.48K550.48K1.38M2.4M1.59M
Pretax Income
-11.78M▲ 0%
-17.17M▼ 45.8%
-30.56M▼ 78.0%
-46.76M▼ 53.0%
-75.97M▼ 62.4%
-84.4M▲ 0%
Pretax Margin %-215.78%-294.5%-954.91%-1709.93%-2810.47%-3945.7%
Income Tax000000
Effective Tax Rate %0%0%0%0%0%0%
Net Income
-11.78M▲ 0%
-17.17M▼ 45.8%
-30.56M▼ 78.0%
-46.02M▼ 50.6%
-76.29M▼ 65.8%
-84.32M▲ 0%
Net Margin %-215.78%-294.5%-954.91%-1682.81%-2822.46%-3941.69%
Net Income Growth %--45.8%-78%-50.58%-65.77%-18.59%
Net Income (Continuing)-11.78M-17.17M-30.56M-46.76M-75.97M-84.4M
Discontinued Operations000000
Minority Interest000-402.83K-79K-339K
EPS (Diluted)
-0.33▲ 0%
-0.48▼ 45.5%
-0.85▼ 77.1%
-1.28▼ 50.6%
-3.77▼ 194.5%
-3.58▲ 0%
EPS Growth %--45.45%-77.08%-50.59%-194.53%-81.73%
EPS (Basic)-0.33-0.48-0.85-1.28-3.77-
Diluted Shares Outstanding35.94M35.94M35.94M35.94M20.25M23.58M
Basic Shares Outstanding35.94M35.94M35.94M35.94M20.25M23.58M
Dividend Payout Ratio------

AVR Balance Sheet

Anteris Technologies Global Corp. (AVR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Total Current Assets6.24M18.75M12.24M24.22M74.65M11.22M
Cash & Short-Term Investments3.36M15.46M9.29M21.03M70.46M9.12M
Cash Only3.36M15.46M9.29M21.03M70.46M9.12M
Short-Term Investments000000
Accounts Receivable652.39K1.85M1.51M1.85M383K234K
Days Sales Outstanding43.63115.94172.72246.2951.7263.69
Inventory534.67K549.82K355.62K442.35K513K436K
Days Inventory Outstanding92.9651.1344.7286.9130.3234.46
Other Current Assets1.7M060.13K61.66K2.66M555K
Total Non-Current Assets3.51M2.68M3.75M6.31M6.05M7.85M
Property, Plant & Equipment1.87M1.92M3.14M5.48M5.86M7.27M
Fixed Asset Turnover2.91x3.04x1.02x0.50x0.46x0.33x
Goodwill000000
Intangible Assets1.09M763.64K607.35K410.15K189K70K
Long-Term Investments000000
Other Non-Current Assets548.3K00417.27K01.03M
Total Assets
9.75M▲ 0%
21.43M▲ 119.7%
15.99M▼ 25.4%
30.53M▲ 91.0%
80.7M▲ 164.3%
19.07M▲ 0%
Asset Turnover0.56x0.27x0.20x0.09x0.03x0.04x
Asset Growth %-119.74%-25.42%90.97%164.35%545.21%
Total Current Liabilities6.04M10.2M6.05M9.46M16.56M13.43M
Accounts Payable581.87K2.23M1.73M3.14M5.89M4.28M
Days Payables Outstanding101.16207.27217.17616.671.5K2.8K
Short-Term Debt1.97M3.38M003K96K
Deferred Revenue (Current)000000
Other Current Liabilities2.82M1.81M1.57M1.77M1.44M0
Current Ratio1.03x1.84x2.02x2.56x4.51x4.51x
Quick Ratio0.94x1.78x1.97x2.51x4.48x4.48x
Cash Conversion Cycle35.42-40.20.27-283.48-1.31K-2.5K
Total Non-Current Liabilities1.85M712.36K907.04K2.17M1.46M2.28M
Long-Term Debt0000026K
Capital Lease Obligations639.32K305.81K439.78K926.78K645K4.5M
Deferred Tax Liabilities000000
Other Non-Current Liabilities1.21M406.54K467.26K1.25M812K2.92M
Total Liabilities7.9M10.91M6.95M11.63M18.02M15.71M
Total Debt2.92M4.14M952.79K1.6M1.4M2.35M
Net Debt-440.56K-11.32M-8.34M-19.43M-69.06M-6.77M
Debt / Equity1.57x0.39x0.11x0.08x0.02x0.02x
Debt / EBITDA------0.03x
Net Debt / EBITDA-----0.08x
Interest Coverage-44.11x-16.30x-47.96x-717.55x-955.76x-816.06x
Total Equity
1.86M▲ 0%
10.52M▲ 467.1%
9.03M▼ 14.2%
18.9M▲ 109.2%
62.68M▲ 231.7%
3.36M▲ 0%
Equity Growth %-467.08%-14.17%109.21%231.68%1970.91%
Book Value per Share0.050.290.250.533.090.14
Total Shareholders' Equity1.86M10.52M9.03M19.3M62.76M3.7M
Common Stock106.97M141.47M169.79M217.33M4K4K
Retained Earnings-103.91M-123.51M-154.07M-200.1M-276.39M-341.33M
Treasury Stock000000
Accumulated OCI-1.2M-7.75M-9.94M-9.56M-10.89M-10.25M
Minority Interest000-402.83K-79K-339K

AVR Cash Flow Statement

Anteris Technologies Global Corp. (AVR) cash flow — operating, investing & free cash flow history

Line itemDec'20Dec'21Dec'22Dec'23Dec'24TTM
Cash from Operations-11.08M-14.44M-29.42M-34.63M-61.24M-61.24M
Operating CF Margin %-203.05%-247.63%-919.07%-1266.32%-2265.67%-
Operating CF Growth %--30.29%-103.74%-17.73%-76.84%-244.38%
Net Income-11.78M-17.17M-30.56M-46.76M-76.29M-84.32M
Depreciation & Amortization1.01M640.09K774.08K1.16M1.97M1.64M
Stock-Based Compensation323.98K254.85K2.94M5.76M03.15M
Deferred Taxes000000
Other Non-Cash Items-6.01M861.55K-817.14K1.23M14.06M1.8M
Working Capital Changes5.38M976.4K-1.75M3.99M-982K214.32K
Change in Receivables4.53M85.45K-533.8K-345.01K-911K224.55K
Change in Inventory862.78K-15.71K194.2K-86.72K-71K23.25K
Change in Payables00000-33.48K
Cash from Investing5.99M-886.07K-992.57K-2.58M-2.28M-562.57K
Capital Expenditures-222.45K-572.87K-1.57M-2.39M-2.27M-1.92M
CapEx % of Revenue4.08%9.83%49.2%87.33%83.83%-
Acquisitions000-213K00
Investments------
Other Investing6.21M-1.4K582.2K19.59K-14K1.36M
Cash from Financing1.46M27.42M23.27M49.34M112.83M76.57M
Debt Issued (Net)-280.7K1.74M-975.45K-808.05K-2.24M-3.34M
Equity Issued (Net)01000K1000K1000K0903K
Dividends Paid000000
Share Repurchases00000-97K
Other Financing1.74M-1.23M-1.05M-2.68M115.07M-767K
Net Change in Cash
-2.94M▲ 0%
12.1M▲ 512.2%
-6.1M▼ 150.4%
11.74M▲ 292.3%
49.37M▲ 320.7%
-1.5M▲ 0%
Free Cash Flow
-11.3M▲ 0%
-15.02M▼ 32.9%
-31.08M▼ 106.9%
-37.03M▼ 19.1%
-63.51M▼ 71.5%
-79.43M▲ 0%
FCF Margin %-207.12%-257.62%-971.12%-1353.89%-2349.5%-3713.38%
FCF Growth %--32.87%-106.94%-19.12%-71.52%-49.08%
FCF per Share-0.31-0.42-0.86-1.03-3.14-3.14
FCF Conversion (FCF/Net Income)0.94x0.84x0.96x0.75x0.80x0.94x
Interest Paid203.2K50.27K33.4K38.47K00
Taxes Paid000000

AVR Key Ratios

Anteris Technologies Global Corp. (AVR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2021202220232024TTM
Return on Equity (ROE)-277.38%-312.54%-329.54%-187.03%-2510.19%
Return on Invested Capital (ROIC)-4070.26%--45271.86%-1696.08%
Gross Margin32.68%9.32%32.06%46.84%67.94%
Net Margin-294.5%-954.91%-1682.81%-2822.46%-3941.69%
Debt / Equity0.39x0.11x0.08x0.02x0.02x
Interest Coverage-16.30x-47.96x-717.55x-955.76x-816.06x
FCF Conversion0.84x0.96x0.75x0.80x0.94x
Revenue Growth6.83%-45.1%-14.56%-1.16%-21.09%

AVR SEC Filings & Documents

Anteris Technologies Global Corp. (AVR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Mar 3, 2026·SEC

Material company update

Jan 22, 2026·SEC

Material company update

Jan 22, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Mar 12, 2025·SEC

10-Q Quarterly Reports

3
FY 2025

Nov 12, 2025·SEC

FY 2025

Aug 11, 2025·SEC

FY 2025

May 13, 2025·SEC

AVR Frequently Asked Questions

Anteris Technologies Global Corp. (AVR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Anteris Technologies Global Corp. (AVR) reported $2.1M in revenue for fiscal year 2024. This represents a 61% decrease from $5.5M in 2020.

Anteris Technologies Global Corp. (AVR) saw revenue decline by 1.2% over the past year.

Anteris Technologies Global Corp. (AVR) reported a net loss of $84.3M for fiscal year 2024.

Dividend & Returns

Anteris Technologies Global Corp. (AVR) has a return on equity (ROE) of -187.0%. Negative ROE indicates the company is unprofitable.

Anteris Technologies Global Corp. (AVR) had negative free cash flow of $79.4M in fiscal year 2024, likely due to heavy capital investments.

Explore More AVR

Anteris Technologies Global Corp. (AVR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.